These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6648143)

  • 61. Prophylactic mastectomy for the prevention of breast cancer.
    Lostumbo L; Carbine N; Wallace J; Ezzo J
    Cochrane Database Syst Rev; 2004 Oct; (4):CD002748. PubMed ID: 15495033
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial.
    Tabar L; Fagerberg G; Chen HH; Duffy SW; Smart CR; Gad A; Smith RA
    Cancer; 1995 May; 75(10):2507-17. PubMed ID: 7736395
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Periodic screening for breast cancer: the HIP Randomized Controlled Trial. Health Insurance Plan.
    Shapiro S
    J Natl Cancer Inst Monogr; 1997; (22):27-30. PubMed ID: 9709271
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Recurrence-free survival in patients with small breast cancer. An analysis of cancers 10 mm or less detected clinically and by screening.
    Arnesson LG; Smeds S; Fagerberg G
    Eur J Surg; 1994 May; 160(5):271-6. PubMed ID: 8075195
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Current controversy on the effectiveness of mammographic screening for breast cancer in western nations].
    Kuriyama S; Tsuji I
    Gan To Kagaku Ryoho; 2004 Feb; 31(2):158-62. PubMed ID: 14997744
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Evaluation of service screening for breast cancer by clinical breast examination using regional cancer registry data].
    Sibata A; Takahashi T; Ouchi N; Fukao A
    Nihon Koshu Eisei Zasshi; 2005 Feb; 52(2):128-36. PubMed ID: 15791899
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Screen-detected breast carcinomas--do they differ from those diagnosed outside screening programs?
    Toikkanen S; Dean PB; Joensuu H
    Pathol Annu; 1994; 29 Pt 1():261-79. PubMed ID: 8127625
    [No Abstract]   [Full Text] [Related]  

  • 68. Life expectancy of screen-detected invasive breast cancer patients compared with women invited to the Nijmegen screening program.
    Otten JD; Broeders MJ; Den Heeten GJ; Holland R; Fracheboud J; De Koning HJ; Verbeek AL
    Cancer; 2010 Feb; 116(3):586-91. PubMed ID: 19998346
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Modeling the impact of the decline in distant stage disease on prostate carcinoma mortality rates.
    Feuer EJ; Mariotto A; Merrill R
    Cancer; 2002 Aug; 95(4):870-80. PubMed ID: 12209732
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Value of mammographic screening: assessment of studies and opinion.
    Alcorn FS
    Radiographics; 1990 Nov; 10(6):1133-9. PubMed ID: 2259768
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Population-Based Breast Cancer Screening With Risk-Based and Universal Mammography Screening Compared With Clinical Breast Examination: A Propensity Score Analysis of 1 429 890 Taiwanese Women.
    Yen AM; Tsau HS; Fann JC; Chen SL; Chiu SY; Lee YC; Pan SL; Chiu HM; Kuo WH; Chang KJ; Wu YY; Chuang SL; Hsu CY; Chang DC; Koong SL; Wu CY; Chia SL; Chen MJ; Chen HH; Chiou ST
    JAMA Oncol; 2016 Jul; 2(7):915-21. PubMed ID: 27030951
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Aggressiveness of screen-detected breast cancers.
    Hakama M; Holli K; Isola J; Kallioniemi OP; Kärkkäinen A; Visakorpi T; Pukkala E; Saarenmaa I; Geiger U; Ikkala J
    Lancet; 1995 Jan; 345(8944):221-4. PubMed ID: 7741862
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening.
    Moss S
    Breast Cancer Res; 2005; 7(5):230-4. PubMed ID: 16168145
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Favourable prognostic factors of subsequent screen-detected breast cancers among women aged 50-69.
    Chiarelli AM; Edwards SA; Sheppard AJ; Mirea L; Chong N; Paszat L; Shumak RS; Oʼmalley FP;
    Eur J Cancer Prev; 2012 Nov; 21(6):499-506. PubMed ID: 22273849
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognosis of screen-detected breast cancers: results of a population based study.
    Cortesi L; Chiuri VE; Ruscelli S; Bellelli V; Negri R; Rashid I; Cirilli C; Fracca A; Gallo E; Federico M
    BMC Cancer; 2006 Jan; 6():17. PubMed ID: 16430776
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Audit procedures in the National Breast Screening Study: mammography interpretation.
    Baines CJ; McFarlane DV; Wall C
    Can Assoc Radiol J; 1986 Dec; 37(4):256-60. PubMed ID: 2950109
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Conditions for Valid Empirical Estimates of Cancer Overdiagnosis in Randomized Trials and Population Studies.
    Gulati R; Feuer EJ; Etzioni R
    Am J Epidemiol; 2016 Jul; 184(2):140-7. PubMed ID: 27358266
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Population screening for breast cancer: an interim assessment].
    van der Maas PJ
    Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1096-9. PubMed ID: 10876703
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Assessment of lead-time bias in estimates of relative survival for breast cancer.
    Andersson TM; Rutherford MJ; Humphreys K
    Cancer Epidemiol; 2017 Feb; 46():50-56. PubMed ID: 28027488
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Assessment of mammography screening and its introduction in Germany in the Statutory Early Diagnosis Program].
    von Fournier D
    Zentralbl Gynakol; 1999; 121(3):159-65. PubMed ID: 10209861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.